Page last updated: 2024-09-05

uic-94003 and urethane

uic-94003 has been researched along with urethane in 6 studies

Compound Research Comparison

Studies
(uic-94003)
Trials
(uic-94003)
Recent Studies (post-2010)
(uic-94003)
Studies
(urethane)
Trials
(urethane)
Recent Studies (post-2010) (urethane)
18044,98636705

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Erickson, JW; Ghosh, AK; Gulnik, SV; Hussain, KA; Kato, R; Kavlick, MF; Maeda, K; Maroun, V; Mitsuya, H; Nguyen, A; Yoshimura, K1
Cho, H; Düzgüneş, N; Ghosh, AK; Hussain, KA; Pretzer, E1
Freire, E; Ohtaka, H; Velázquez-Campoy, A; Xie, D1
DeGoey, DA; Randolph, JT1
Chen, H; Duan, Y; Han, JG; Li, D; Li, L; Liu, G; Zhao, RN1
Haridev, S; Kar, P; Roy, R; Sk, MF1

Reviews

1 review(s) available for uic-94003 and urethane

ArticleYear
Peptidomimetic inhibitors of HIV protease.
    Current topics in medicinal chemistry, 2004, Volume: 4, Issue:10

    Topics: Anti-HIV Agents; Atazanavir Sulfate; Carbamates; Clinical Trials as Topic; Dipeptides; Furans; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Models, Molecular; Molecular Mimicry; Molecular Structure; Nelfinavir; Oligopeptides; Organophosphates; Peptides; Phenylbutyrates; Pyridines; Pyrimidinones; Ritonavir; Saquinavir; Sulfonamides; Urethane

2004

Other Studies

5 other study(ies) available for uic-94003 and urethane

ArticleYear
A potent human immunodeficiency virus type 1 protease inhibitor, UIC-94003 (TMC-126), and selection of a novel (A28S) mutation in the protease active site.
    Journal of virology, 2002, Volume: 76, Issue:3

    Topics: Alanine; Amino Acid Sequence; Catalytic Domain; Cell Line; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Laboratories; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; Protein Structure, Tertiary; Sequence Homology, Amino Acid; Serine; Sulfonamides; Urethane

2002
Antiviral activity of UIC-PI, a novel inhibitor of the human immunodeficiency virus type 1 protease.
    Antiviral research, 2002, Volume: 54, Issue:1

    Topics: Cell Line; HIV Core Protein p24; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Molecular Structure; Saquinavir; Sulfonamides; Urethane

2002
Overcoming drug resistance in HIV-1 chemotherapy: the binding thermodynamics of Amprenavir and TMC-126 to wild-type and drug-resistant mutants of the HIV-1 protease.
    Protein science : a publication of the Protein Society, 2002, Volume: 11, Issue:8

    Topics: Binding Sites; Calorimetry; Carbamates; Drug Design; Drug Resistance, Viral; Escherichia coli; Furans; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Kinetics; Models, Molecular; Mutagenesis, Site-Directed; Protein Binding; Sulfonamides; Thermodynamics; Urethane

2002
Insights into the structural function of the complex of HIV-1 protease with TMC-126: molecular dynamics simulations and free-energy calculations.
    Journal of molecular modeling, 2012, Volume: 18, Issue:5

    Topics: Alanine; Catalytic Domain; HIV Protease; HIV Protease Inhibitors; HIV-1; Kinetics; Molecular Dynamics Simulation; Protein Binding; Sulfonamides; Thermodynamics; Urethane

2012
Investigating potency of TMC-126 against wild-type and mutant variants of HIV-1 protease: a molecular dynamics and free energy study.
    SAR and QSAR in environmental research, 2021, Volume: 32, Issue:11

    Topics: Anti-HIV Agents; HIV Protease; Molecular Dynamics Simulation; Sulfonamides; Urethane

2021